October 23, 2024
A N N O U N C E M E N T
regarding the Publication of the Consolidated Financial Results
for 9 months and Q3 2024
S.N.G.N. Romgaz S.A. informs the shareholders and investors about the publication of the Consolidated Financial Results of ROMGAZ Group for the 9-month period and Q3 ending September 30, 2024 and the organisation of a conference call, namely:
Ø The Quarterly Report and the Consolidated Condensed Interim Financial Statements for the 9-month period and Q3 ending September 30, 2024 (not audited) will be published on November 15, 2024, 8:30 AM (Romania time):
· on Bucharest Stock Exchange website, www.bvb.ro - symbol SNG;
· on London Stock Exchange website, www.londonstockexchange.com - symbol SNGR;
· on the company's website, www.romgaz.ro, at Investors - Interim Reports and
· printed, at the Company's headquarters located in Medias, 4 C.I. Motas Square, Sibiu County.
The consolidated condensed interim financial statements are prepared according to the International Accounting Standard 34 and are not audited by the independent auditor.
A presentation of ROMGAZ Group will be available starting with November 15, 2024 on www.romgaz.ro , at Investors - Summary Results and Presentations for Investors.
Ø The conference call with the investors and financial analysts to discuss the financial results is scheduled for November 15, 2024, starting with 1:00 PM (Romania time). The conference call will be held in English.
Information regarding the attendance to the event will be available starting with November 4, 2024, on the company's website, www.romgaz.ro, at Investors - News & Events - ROMGAZ Conference Call Q3 2024 15 11 2024 or by accessing the following link:
https://romgaz.webex.com/weblink/register/r02afd728d40a50ccc3ab40f04d8b5296
Chief Executive Officer,
Razvan POPESCU
Chief Financial Officer,
Gabriela TRANBITAS
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.